Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection

Infection and Immunity

Volumn 68, Issue 6, 2000, Pages 3748-3753

  Rayhane, Naïma ^a   Fitting, Catherine ^a   Lortholary, Olivier ^a   Dromer, Francoise ^a   Cavaillon, Jean Marc ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE SYNTHASE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; MALE; MOUSE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

ANIMALS; BRAIN; CRYPTOCOCCOSIS; CYTOKINES; ENDOTOXINS; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED BALB C; PENTOXIFYLLINE; SPLEEN;

EID: 0034085079     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.6.3748-3753.2000     Document Type: Article

References (26)

1. Aguirre, K., E. A. Havell, G. W. Gibson, and L. L. Johnson. 1995. Role of tumor necrosis factor and gamma interferon in acquired resitance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:1725-1731.
2. Cavaillon, J. M., C. Pitton, and C. Fitting. 1994. Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGFβ. J Endotoxin Res. 1:21-29.
3. Colletti, L. M., D. G. Remick, and D. A. Campbell. 1994. LPS pretreatment protects from hepatic ischemia/reperfusion. J. Surg. Res. 57:337-343.
4. Collins, H. L., and G. J. Bancroft. 1992. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 22:1447-1454.
5. Eising, G. P., L. Mao, G. W. Schmid-Schönbein, R. L. Engler, and J. Ross. 1996. Effects of induced tolerance to bacterial lipopolysaccharide on myocardial infarct size in rats. Cardiovasc. Res. 31:73-81.
6. Han, J., P. Thompson, and B. Beutler. 1990. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling patway. J. Exp. Med. 172:391-394.
7. He, W., Y. Fong, M. A. Marano, J. E. Gershenwald, R. W. Yurt, L. L. Moldawer, and S. F. Lowry. 1992. Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenuated cytokine responses. J. Infect. Dis. 165:859-864.
8. Heemann, U., A. Szabo, P. Hamar, V. Müller, O. Witzke, J. Lutz, and T. Philipp. 2000. Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury. Possible connection to an interleukin-6 dependent pathway. Am. J. Pathol. 156:287-293.
9. Huffnagle, G. B., G. B. Toews, M. D. Burdick, M. B. Boyd, K. S. McAllister, R. A. McDonald, S. L. Kunkel, and R. M. Strieter. 1996. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 157:4529-4536.
10. Kawakami, K., X. Qifeng, M. Tohyama, M. H. Qureshi, and A. Saito. 1996. Contribution of tumour necrosis factor-alpha (TNF-alpha) in host defence mechanism against Cryptococcus neoformans. Clin. Exp. Immunol. 106:468-474.
11. Lortholary, O., L. Improvisi, N. Rayhane, F. Gray, C. Fitting, J.-M. Cavaillon, and F. Dromer. 1999. Cytokines profiles are similar in AIDS patients and in mice with disseminated Cryptococcus neoformans infection. Infect. Immun. 67:6314-6320.
12. Marie, C., J. Muret, C. Fitting, M.-R. Losser, D. Payen, and J.-M. Cavaillon. 1998. Reduced ex vivo interleukin-8 production by neutrophils in septic and non-septic systemic inflammatory response syndrome. Blood 91:3439-3446.
13. Mason, C. M., E. Dobard, W. R. Summer, and S. Nelson. 1997. Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms. J. Infect. Dis. 176:1293-1302.
14. Minami, A., K. Fujimoto, Y. Ozaki, and S. Nakamura. 1988. Augmentation of host resistance to microbial infections by recombinant human interleukin-1 alpha. Infect. Immun. 56:3116-3120.
15. Mitchell, T. G., and J. R. Perfect. 1995. Cryptococcosis in the era of AIDS -100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:515-548.
16. Müller-Alouf, H., J. E. Alouf, D. Gerlach, C. Fitting, and J. M. Cavaillon. 1992. Cytokine production by murine cells activated by erythrogenic toxin type A superantigen of Streptococcus pyogenes. Immunobiology 186:435-448.
17. Nansen, A., J. Pravsgaard Christensen, O. Marker, and A. Randrup Thomsen. 1997. Sensitization to lipopolysaccharide in mice with asymptomatic viral infection: role of T-cell-dependent production of interferon-γ. J. Infect. Dis. 176:151-157.
18. Rayhane, N., C. Fitting, and J.-M. Cuvaillon. 1999. Dissociation of IFNγ from IL-12 and IL-18 during endotoxin tolerance. J. Endotoxin Res. 5:319-324.
19. Rayhane, N., O. Lortholary, C. Fitting, J. Callebert, M. Huerre, F. Dromer, and J.-M. Cavaillon. 1999. Enhanced sensitivity of tumor necrosis factor/ lymphotoxin-α deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, gamma-interferon and interleukin-12. J. Infect. Dis. 180:1637-1647.
20. Roilides, E., C. A. Lyman, S. D. Mertins, D. J. Cole, D. Venzon, P. A. Pizzo, S. J. Chanock, and T. J. Walsh. 1996. Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens. Cytokine 8:42-48.
21. Rothstein, J. L., and H. Schreiber. 1988. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc. Natl. Acad. Sci. USA 85:607-611.
22. Salkowski, C. A., C. Detore, A. Franks, M. C. Falk, and S. N. Vogel. 1998. Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect. Immun. 66:3569-3578.
23. Schade, U. F. 1990. Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circ. Shock. 31: 171-181.
24. Severn, A., D. Xu, J. Doyle, L. M. Leal, C. A. O'Donnell, S. J. Brett, D. W. Moss, and F. Y. Liew. 1993. Pre-exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity. Eur. J. Immunol. 23:1711-1714.
25. Welty-Wolf, K. E., M. S. Carraway, Y.-C. T. Huang, S. G. Simonson, S. P. Kantrow, and C. A. Piantadosi. 1998. Bacterial priming increases lung injury in Gram negative sepsis. Am. J. Respir. Crit. Care Med. 158:610-619.
26. Youngner, J. S., and W. R. Stinebring. 1965. Interferon appearance stimulated by endotoxin bacteria or viruses in mice pre-treated with Escherichia coli endotoxin or infected with Mycobacterium tuberculosis. Nature 208:456-458.